Quantcast

Latest drug discovery Stories

2014-09-25 12:30:11

DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process. 'Outsourcing in Drug Discovery' provides an in depth look into the...

2014-09-23 08:31:59

TORONTO, Sept. 23, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd (PPL) has added two more consultants to its team for further development of its PPL-003 for uveitis. PPL-003 uses a new proprietary cell permeable peptide platform technology derived from human genes to deliver its anti-inflammatory cargo into the eye. Ms....

2014-09-23 08:29:59

NOK 16 million awarded to develop novel cancer therapeutics BERGEN, Norway, September 23, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces it has been granted a GBP1.6 million (NOK 16 million) Seeding Drug Discovery Award from the UK's Wellcome Trust to develop novel small molecule inhibitors against BGB002, its proprietary, novel cancer target. The Wellcome Trust Seeding Drug Discovery Awards are to...

2014-09-23 08:29:34

President-Elect of the Society for Cryobiology and Former Cell Therapy Executive Join Leading Clinicians, Developers, and Consultants in the Biobanking, Drug Discovery, and Regenerative Medicine Markets BOTHELL, Wash., Sept. 23, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or...

2014-09-22 08:28:07

DALLAS, September 22, 2014 /PRNewswire/ -- According to the new market research report "Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application (Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019", published by MarketsandMarkets, analyzes and studies the major market drivers, threats, opportunities, and challenges. Browse...

2014-09-18 12:27:56

LONDON, Sept. 18, 2014 /PRNewswire/ -- This report gives you a new and unique way of stratifying and analyzing the global melanoma pipeline and presents actionable analysis which allows you to discover:* Where the competition is; Which targets and companies are setting the path?* What is first-in-class in the melanoma pipeline?* Is First-in-Class the Best-in-Class?* Indication expansion opportunities* Drug repositioning opportunities* Which pathways are targeted, by what and how?*...

2014-09-18 08:29:10

Drug Development Team Now Complete and Fully Focused on Clinical Trial Implementation NEW YORK, Sept. 18, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development. During his extensive career in Clinical Research, Mr. James has established and led successful global...

2014-09-17 23:14:27

The Freeslate Core Module 3 Reaction Screening System will be used to advance small molecule organic chemistry research objectives Sunnyvale, CA (PRWEB) September 17, 2014 Freeslate, Inc., the leading provider of high throughput research solutions for drug development, today announced that Baylor University acquired a Freeslate Core Module 3 (CM3) Reaction Screening System to both support Baylor research interests and provide screening services to the Texas community. Freeslate’s high...

2014-09-17 16:27:36

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 /PRNewswire/ -- The In Silico Drug Discovery Conference today announced speakers and presentation topics that will be featured at the conference, which takes place at North Carolina Biotechnology Center's Hamner Conference Center on December 3 and 4, 2014. Researchers, students, drug developers, business development professionals, and biotechnology managers are invited to hear the following: KEYNOTE SPEAKERS Ruben Abagyan, PhD UC San Diego Skaggs...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related